Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT04162769

Public ClinicalTrials.gov record NCT04162769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 12:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled 16-Week Study (With a 52-Week Open-Label Extension) to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Study identification

NCT ID
NCT04162769
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Arena Pharmaceuticals
Industry
Enrollment
140 participants

Conditions and interventions

Interventions

  • Etrasimod 1 mg Drug
  • Etrasimod 2 mg Drug
  • Etrasimod matching placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2019
Primary completion
Sep 8, 2020
Completion
Oct 10, 2021
Last update posted
Nov 3, 2022

2019 – 2021

United States locations

U.S. sites
35
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Noble Clinical Research Tucson Arizona 85704
Hope Clinical Research Canoga Park California 91303
First OC Dermatology Fountain Valley California 92708
Marvel Research LLC Huntington Beach California 92647
ADVA Clinical Research, Inc Inglewood California 90301
Providence Clinical Research North Hollywood California 91606
TCR Medical Corporation San Diego California 92123
Clinical Research of West Florida Clearwater Florida 33765
Prohealth Research Center Doral Florida 33166
Aby's New Generation Research, Inc. Hialeah Florida 33016
Skin Care Research, LLC Hollywood Florida 33021
Advanced Research Institute of Miami LLC Homestead Florida 33030
Amber Pediatrics Research, LLC Homestead Florida 33030
South Miami Medical & Research Group. Inc Miami Florida 33155
Amber Pediatrics Research, LLC Miami Florida 33169
Skin Research of South Florida Miami Florida 33173
Amber Clinical Research, LLC Miami Shores Florida 33138
IMA Clinical Research, LLC St. Petersburg Florida 33709
Clinical Research of West Florida, Inc. Tampa Florida 33603
Rophe Adult and Pediatric Medicine/SKYCRNG Union City Georgia 30291
Skin Sciences PLLC Louisville Kentucky 40217
Quinn Healthcare/SKYCRNG Ridgeland Mississippi 39157
Quality Clinical Research Inc Omaha Nebraska 68114
Excel Clinical Research Las Vegas Nevada 89109
Greenwich Village Dermatology New York New York 10012
ODRC Enterprises, LLC dba Oregon Dermatology and Research Center Portland Oregon 97210
Spartanburg Medical Research Spartanburg South Carolina 29369
Health Concepts Rapid City South Dakota 57702
Gadolin Research Beaumont Texas 77702
Modern Research Associates, PLLC Dallas Texas 75231
FMC Science Georgetown Texas 78626
FMC Science Lampasas Texas 76550
Alliance for Multispecialty Research Norfolk Virginia 23507
Clinical Research Partners, LLC Richmond Virginia 23220
Premier Clinical Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04162769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2022 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04162769 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →